Cardinal health reports fourth quarter and fiscal year 2024 results and raises fiscal year 2025 guidance

Fourth quarter revenue increased 12% to $59.9 billion fourth quarter gaap1 operating earnings were $401 million and gaap diluted eps was $0.96 fourth quarter non-gaap operating earnings increased 14% to $605 million and non-gaap diluted eps increased 29% to $1.84 fiscal year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion, respectively fiscal year 2025 non-gaap eps guidance raised to $7.55 to $7.70, from at least $7.50 dublin, ohio , aug. 14, 2024 /prnewswire/ -- cardinal health (nyse: cah) today reported fourth quarter fiscal year 2024 revenues of $59.9 billion, an increase of 12% from the prior year. gaap operating earnings were $401 million and gaap diluted earnings per share (eps) were $0.96.
CAH Ratings Summary
CAH Quant Ranking